State Key Laboratory of Estuarine and Coastal Research, School of Life Sciences, East China Normal University, Shanghai, China.
State Key Laboratory of Estuarine and Coastal Research, School of Life Sciences, East China Normal University, Shanghai, China.
J Biol Chem. 2023 Feb;299(2):102843. doi: 10.1016/j.jbc.2022.102843. Epub 2022 Dec 26.
Transforming growth factor-β1 (TGF-β1) can suppress the activation, proliferation, and function of many T-cell subsets, protecting organisms from inflammatory and autoimmune disease caused by an overexuberant immune response. However, whether and how TGF-β1 regulates T-cell immunity in early vertebrates remain unknown. Here, using a Nile tilapia (Oreochromis niloticus) model, we investigated suppression of the T-cell response by TGF-β1 in teleost species. Tilapia encodes an evolutionarily conserved TGF-β1, the expression of which in lymphocytes is significantly induced during the immune response following Edwardsiella piscicida infection. Once activated, tilapia T cells increase TGF-β1 production, which in turn suppresses proinflammatory cytokine expression and inhibits T-cell activation. Notably, we found administration of TGF-β1 cripples the proliferation of tilapia T cells, reduces the potential capacity of Th1/2 differentiation, and impairs the cytotoxic function, rendering the fish more vulnerable to bacterial infection. Mechanistically, TGF-β1 initiates the TGF-βR/Smad signaling pathway and triggers the phosphorylation and nuclear translocation of Smad2/3. Smad3 subsequently interacts with several transcriptional partners to repress transcription of cytokines IL-2 and IFN-γ but promote transcription of immune checkpoint regulator CTLA4 and transcription factor Foxp3. Furthermore, TGF-β1/Smad signaling further utilizes Foxp3 to achieve the cascade regulation of these T-cell genes. Taken together, our findings reveal a detailed mechanism by which TGF-β1 suppresses the T cell-based immunity in Nile tilapia and support the notion that TGF-β1 had already been employed to inhibit the T-cell response early in vertebrate evolution, thus providing novel insights into the evolution of the adaptive immune system.
转化生长因子-β1(TGF-β1)可以抑制许多 T 细胞亚群的激活、增殖和功能,从而保护机体免受过度活跃的免疫反应引起的炎症和自身免疫性疾病的影响。然而,TGF-β1 是否以及如何调节早期脊椎动物的 T 细胞免疫仍然未知。在这里,我们使用罗非鱼(Oreochromis niloticus)模型研究了 TGF-β1在硬骨鱼类中对 T 细胞免疫的抑制作用。罗非鱼编码了一种进化上保守的 TGF-β1,其在淋巴细胞中的表达在爱德华氏菌感染后的免疫反应中显著上调。一旦被激活,罗非鱼 T 细胞增加 TGF-β1 的产生,这反过来又抑制促炎细胞因子的表达并抑制 T 细胞的激活。值得注意的是,我们发现 TGF-β1 的给药会削弱罗非鱼 T 细胞的增殖,降低 Th1/2 分化的潜在能力,并损害细胞毒性功能,使鱼更容易受到细菌感染。在机制上,TGF-β1 启动 TGF-βR/Smad 信号通路并触发 Smad2/3 的磷酸化和核易位。Smad3 随后与几个转录伙伴相互作用,抑制细胞因子 IL-2 和 IFN-γ 的转录,但促进免疫检查点调节剂 CTLA4 和转录因子 Foxp3 的转录。此外,TGF-β1/Smad 信号进一步利用 Foxp3 来实现这些 T 细胞基因的级联调节。总之,我们的研究结果揭示了 TGF-β1 抑制尼罗罗非鱼 T 细胞免疫的详细机制,并支持 TGF-β1 早在脊椎动物进化早期就被用来抑制 T 细胞反应的观点,从而为适应性免疫系统的进化提供了新的见解。